CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,765)	$ (3,103)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	1	2
Depreciation	7	7
Amortization of debt issuance costs and discounts	72	97
Stock-based compensation	133	1,860
Change in fair value of derivative liability	8	(5)
Amortization of lease right-of-use-asset	64	56
Gain from forgiveness of debt	(49)	(69)
Other non-cash expenses	14	20
Change in operating assets and liabilities:
Accounts receivable	4	(3)
Inventory	(4)	(99)
Other current assets	82	74
Accounts payable and accrued liabilities	389	(130)
Lease liabilities	(67)	(58)
Deferred revenue	324	(59)
NET CASH USED IN OPERATING ACTIVITIES	(787)	(1,410)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of notes payable	312	0
Proceeds from the issuance of notes payable issued to related parties	75	0
Payments made on notes payable	(239)	(367)
Payments made on notes payable issued to related parties	(29)	0
Payments of debt issuance costs	(29)	0
Proceeds from issuance of common stock, net of costs	300	0
Proceeds from warrant exercises	0	195
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	390	(172)
NET CHANGE IN CASH	(397)	(1,582)
Cash at beginning of period	591	2,313
CASH AT END OF PERIOD	194	731
SUPPLEMENTAL DISCLOSURE FOR OPERATING ACTIVITIES:
Cash paid for interest	25	97
SUPPLEMENTAL DISCLOSURE FOR NON-CASH INVESTING AND FINANCING ACTIVITIES:
Dividends on preferred stock	126	122
Deemed dividends for warrant exchanges	0	65
Warrants issued with debt	27	0
Fair value of beneficial conversion features	12	0
Settlement of interest through common stock issuance	126	119
Settlement of dividends through common stock issuance	168	166
Settlement of previously accrued professional fees through common stock issuance	57	167
Accrued payroll liability exchanged for promissory note	87	0
Directors and Officers Insurance obtained with Financing	130	119
Conversion of Series E preferred shares into common stock	0	5
Conversion of Series F preferred shares into common stock	0	42
Conversion of Series F-2 preferred shares into common stock	$ 0	$ 14